SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-230179

SYN-025

[SYN] November Quasar · 64y · Female · Chinese · BMI 22.2 · ECOG 0
SMCAS - Sunway Medical Centre AS · Cardiothoracic Surgery · Dr. Faisal Hashim
IIB (T3, N0)Stable
ALK fusion
Clinical storyline

[SYN] November Quasar, a 64-year-old Chinese female (never, ECOG 0), presented in 2023-12 with unintentional weight loss (~5kg over 3 months). Workup confirmed Adenocarcinoma (Stage II, ALK fusion). The MDT recommended curative-intent surgery. Current status: Stable.

HPE Results
Adenocarcinoma: Acinar, ALK rearranged
Clinical Stage
IIB (T3, N0)
Pathological Stage
IIB (T3, N0, Mx)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
5.8
Tumor (CT/PET)
5.1 cm
PET SUV
5.94
NGS Results
ALK fusion positive (EML4-ALK)